Thymic source restoration is a strong immune upstream entry, but not yet a universal longevity bottleneck

Thymic source restoration: unified takeaway

''Conclusion'': Thymic source restoration is an upstream immune intervention with emerging healthspan evidence, but it is not yet a validated universal longevity bottleneck.

How to use it

# Treat it as a strong candidate when the bottleneck is immune source decline or thymic involution.
# Do not assume it generalizes to all aging contexts without stronger causal and outcome evidence.
# Prefer context-specific prioritization over universal claims.